Multimodality US Based on Angio Planewave Ultrasensitive Imaging and Shear Wave Elastography to Evaluate the Malignancy Risk Value of Thyroid Nodules
Launched by FIFTH AFFILIATED HOSPITAL, SUN YAT-SEN UNIVERSITY · Jul 30, 2024
Trial Information
Current as of September 11, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to use ultrasound technology to help doctors tell the difference between harmless (benign) and harmful (malignant) thyroid nodules. It uses advanced imaging techniques, including a special type of ultrasound called Angio Planewave Ultrasensitive Imaging and another method called Shear Wave Elastography, along with standard grayscale ultrasound. The main aim is to see if these combined methods can improve the accuracy of diagnosing thyroid nodules and guide doctors in deciding if a needle biopsy is needed.
To participate in this trial, individuals must be over 18 years old, have at least one thyroid nodule that can be seen on an ultrasound, and be willing to undergo surgery to confirm the results. Participants will have a series of ultrasound tests within a week before their surgery. It’s important to note that those with certain conditions, like large calcifications in the nodules or a history of neck surgery or cancer, may not be eligible. This research could lead to better ways of diagnosing thyroid issues, which is important for ensuring patients get the right treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. age more than 18 years;
- • 2. Voluntarily signed informed consent;
- • 3. Have 1 or more thyroid nodules detectable by ultrasound;
- • 4. participant underwent surgical procedure to confirm the pathologic results
- Exclusion Criteria:
- • 1. Nodules are accompanied by large calcifications followed by acoustic shadows
- • 2. History of previous neck surgery or cancer, thyroid medications, radiation or surgical treatment;
- • 3. Poor quality of retained images or non-standard operations (such as intermittent scanning and improper probe compression), and incomplete pathological results.
About Fifth Affiliated Hospital, Sun Yat Sen University
The Fifth Affiliated Hospital of Sun Yat-sen University is a leading clinical research institution dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. As part of a prestigious university network, the hospital combines cutting-edge research capabilities with comprehensive healthcare services. It is committed to conducting high-quality, ethically sound clinical studies across various medical disciplines, fostering collaboration between researchers, healthcare professionals, and industry partners. With a focus on translating research findings into practical applications, the Fifth Affiliated Hospital aims to enhance treatment options and outcomes for patients both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zhuhai, Guangdong, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported